Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: incomplete Freund's adjuvant|BIOLOGICAL: sargramostim|BIOLOGICAL: telomerase: 540-548 peptide vaccine
Sponsor: Abramson Cancer Center at Penn Medicine
Collaborators: National Cancer Institute (NCI)